newsfilter
← Latest News
PR Newswire·

PDL BioPharma Announces Completion of Strategic Review Process

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announced today that it has completed the strategic review process that it initiated in...